Tag: veterinary active pharmaceutical ingredients manufacturing market share

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has the Veterinary Active Pharmaceutical Ingredients Manufacturing Market Grown from 2024 to 2025?

The market for manufacturing active pharmaceutical ingredients for veterinary use has been on a significant upward trend in the past few years. The market size is projected to rise from $7.46 billion in 2024 to $8.05 billion in 2025, registering a compound annual growth rate (CAGR) of 7.9%. This growth trajectory seen in the historical period is largely influenced by factors such as an increase in pet ownership, the enforcement of strict regulatory standards, heightened emphasis on animal nutrition, increased investment in research and development, and general global economic growth.

What Growth Rate Is Anticipated for the Veterinary Active Pharmaceutical Ingredients Manufacturing Market in the Coming Years?

The market for manufacturing veterinary active pharmaceutical ingredients is projected to experience robust growth in the coming years, escalating to a worth of $11.19 billion in 2029 with a compound annual growth rate (CAGR) of 8.6%. This projected growth during the forecast period can be credited to factors such as the development of tailored veterinary medicine, global expansion and market proliferation, a heightened focus on regulatory adherence, the growing significance of animal well-being, progress in drug delivery systems, and an increased demand for nutraceuticals. Foreseen trends in this growth span include advancements in manufacturing methodologies, a rising trend in the outsourcing of API manufacturing, a transformation towards biotech-based APIs, the incorporation of digitalization and automation in production, and the globalization of the veterinary API market.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7942&type=smp

Who Are the Leading Companies in the Veterinary Active Pharmaceutical Ingredients Manufacturing Market?

Major companies operating in the veterinary active pharmaceutical ingredients manufacturing market are Alivira Animal Health Limited, Excel Industries Limited, Ofichem Group B.V., Jiangsu Lingyun Pharmaceutical Co. Ltd., SUANFARMA S.A., NGL Fine-Chem Limited, FIS – Fabbrica Italiana Sintetici S.p.A., Lupin Limited, Aurobindo Pharma Limited, Saneca Pharmaceuticals AS, Neuland Laboratories Limited, Divi’s Laboratories Limited, Zoetis Inc., Grupo Indukern S.L., Sequent Scientific Limited, Chempro Pharma Private Limited, AMGIS Lifescience Ltd., Huvepharma AD, Vetpharma Animal Health S.L., Qilu Pharma Spain S.A., INDUKERN Chemie AG, Chemopharma S.A., Norbrook Laboratories Limited, Ceva Santé Animale S.A., Vetoquinol S.A., Virbac S.A.

What Are the Key Drivers of the Veterinary Active Pharmaceutical Ingredients Manufacturing Market?

The rise in pet adoption is anticipated to boost the expansion of the market for manufacturing veterinary active pharmaceutical ingredients. Pet keepers are those who possess or adopt a pet animal and offer necessary healthcare arrangements for their pets, thereby escalating the need for veterinary medicines. As an example, Animal Medicines Australia, a non-profit organization based in Australia, reported a significant increase in pet ownership in the year 2022. They documented an increase from 39% in 2021 to 28,730.8 pet owners in 2022, marking a 24% growth. This indicates a significant surge in the adoption of pets and investments in pet care, underlining the mounting popularity of pets in Australian homes. Consequently, the rising number of individuals owning pets fuels the market for the production of veterinary active pharmaceutical ingredients.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=7942&type=smp

What Are the Key Market Segments in the Veterinary Active Pharmaceutical Ingredients Manufacturing Industry?

The veterinary active pharmaceutical ingredients manufacturing market covered in this report is segmented –

1) By Product: Antiparasitic, Anti-Infectives, Vaccines, NSAIDs

2) By Service Type: In House, Contract Outsourcing

3) By Synthesis Type: Chemical Based API, Biological API, Highly Potent API

Subsegments:

1) By Antiparasitic: Endectocides, Anthelmintics, Antiprotozoals

2) By Anti-Infectives: Antibiotics, Antifungals, Antivirals

3) By Vaccines: Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines

4) By NSAIDs (Non-Steroidal Anti-Inflammatory Drugs): Non-Selective NSAIDs, COX-2 Inhibitors

What Are the Latest Trends in the Veterinary Active Pharmaceutical Ingredients Manufacturing Market?

One significant trend that is emerging in the veterinary active pharmaceutical ingredient manufacturing market is product innovation. To maintain their dominance in the market, the leading companies are focusing on developing innovative products. For example, in January 2022, Zoetis Inc., a US-based company that manufactures drugs for livestock and pets, received approval from the US FDA for Solensia (frunevetmab injection), designed to manage osteoarthritis (OA) pain in cats. Solensia, which is the only injectable monoclonal antibody therapy for feline OA pain approved in the United States, functions by targeting and neutralizing nerve growth factor (NGF), a primary contributor to osteoarthritis pain.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/veterinary-active-pharmaceutical-ingredients-manufacturing-global-market-report

What Are the Key Regional Markets in the Veterinary Active Pharmaceutical Ingredients Manufacturing Industry?

North America was the largest region in the veterinary active pharmaceutical ingredients manufacturing market in 2024. The regions covered in the veterinary active pharmaceutical ingredients manufacturing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7942

This Report Delivers Insight On:

1. How big is the veterinary active pharmaceutical ingredients manufacturing market, and how is it changing globally?

2. Who are the major companies in the veterinary active pharmaceutical ingredients manufacturing market, and how are they performing?

3. What are the key opportunities and risks in the veterinary active pharmaceutical ingredients manufacturing market right now?

4. Which products or customer segments are growing the most in the veterinary active pharmaceutical ingredients manufacturing market?

5. What factors are helping or slowing down the growth of the veterinary active pharmaceutical ingredients manufacturing market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has the Veterinary Active Pharmaceutical Ingredients Manufacturing Market Grown from 2024 to 2025?

The market for manufacturing active pharmaceutical ingredients for veterinary use has been on a significant upward trend in the past few years. The market size is projected to rise from $7.46 billion in 2024 to $8.05 billion in 2025, registering a compound annual growth rate (CAGR) of 7.9%. This growth trajectory seen in the historical period is largely influenced by factors such as an increase in pet ownership, the enforcement of strict regulatory standards, heightened emphasis on animal nutrition, increased investment in research and development, and general global economic growth.

What Growth Rate Is Anticipated for the Veterinary Active Pharmaceutical Ingredients Manufacturing Market in the Coming Years?

The market for manufacturing veterinary active pharmaceutical ingredients is projected to experience robust growth in the coming years, escalating to a worth of $11.19 billion in 2029 with a compound annual growth rate (CAGR) of 8.6%. This projected growth during the forecast period can be credited to factors such as the development of tailored veterinary medicine, global expansion and market proliferation, a heightened focus on regulatory adherence, the growing significance of animal well-being, progress in drug delivery systems, and an increased demand for nutraceuticals. Foreseen trends in this growth span include advancements in manufacturing methodologies, a rising trend in the outsourcing of API manufacturing, a transformation towards biotech-based APIs, the incorporation of digitalization and automation in production, and the globalization of the veterinary API market.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7942&type=smp

Who Are the Leading Companies in the Veterinary Active Pharmaceutical Ingredients Manufacturing Market?

Major companies operating in the veterinary active pharmaceutical ingredients manufacturing market are Alivira Animal Health Limited, Excel Industries Limited, Ofichem Group B.V., Jiangsu Lingyun Pharmaceutical Co. Ltd., SUANFARMA S.A., NGL Fine-Chem Limited, FIS – Fabbrica Italiana Sintetici S.p.A., Lupin Limited, Aurobindo Pharma Limited, Saneca Pharmaceuticals AS, Neuland Laboratories Limited, Divi’s Laboratories Limited, Zoetis Inc., Grupo Indukern S.L., Sequent Scientific Limited, Chempro Pharma Private Limited, AMGIS Lifescience Ltd., Huvepharma AD, Vetpharma Animal Health S.L., Qilu Pharma Spain S.A., INDUKERN Chemie AG, Chemopharma S.A., Norbrook Laboratories Limited, Ceva Santé Animale S.A., Vetoquinol S.A., Virbac S.A.

What Are the Key Drivers of the Veterinary Active Pharmaceutical Ingredients Manufacturing Market?

The rise in pet adoption is anticipated to boost the expansion of the market for manufacturing veterinary active pharmaceutical ingredients. Pet keepers are those who possess or adopt a pet animal and offer necessary healthcare arrangements for their pets, thereby escalating the need for veterinary medicines. As an example, Animal Medicines Australia, a non-profit organization based in Australia, reported a significant increase in pet ownership in the year 2022. They documented an increase from 39% in 2021 to 28,730.8 pet owners in 2022, marking a 24% growth. This indicates a significant surge in the adoption of pets and investments in pet care, underlining the mounting popularity of pets in Australian homes. Consequently, the rising number of individuals owning pets fuels the market for the production of veterinary active pharmaceutical ingredients.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=7942&type=smp

What Are the Key Market Segments in the Veterinary Active Pharmaceutical Ingredients Manufacturing Industry?

The veterinary active pharmaceutical ingredients manufacturing market covered in this report is segmented –

1) By Product: Antiparasitic, Anti-Infectives, Vaccines, NSAIDs

2) By Service Type: In House, Contract Outsourcing

3) By Synthesis Type: Chemical Based API, Biological API, Highly Potent API

Subsegments:

1) By Antiparasitic: Endectocides, Anthelmintics, Antiprotozoals

2) By Anti-Infectives: Antibiotics, Antifungals, Antivirals

3) By Vaccines: Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines

4) By NSAIDs (Non-Steroidal Anti-Inflammatory Drugs): Non-Selective NSAIDs, COX-2 Inhibitors

What Are the Latest Trends in the Veterinary Active Pharmaceutical Ingredients Manufacturing Market?

One significant trend that is emerging in the veterinary active pharmaceutical ingredient manufacturing market is product innovation. To maintain their dominance in the market, the leading companies are focusing on developing innovative products. For example, in January 2022, Zoetis Inc., a US-based company that manufactures drugs for livestock and pets, received approval from the US FDA for Solensia (frunevetmab injection), designed to manage osteoarthritis (OA) pain in cats. Solensia, which is the only injectable monoclonal antibody therapy for feline OA pain approved in the United States, functions by targeting and neutralizing nerve growth factor (NGF), a primary contributor to osteoarthritis pain.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/veterinary-active-pharmaceutical-ingredients-manufacturing-global-market-report

What Are the Key Regional Markets in the Veterinary Active Pharmaceutical Ingredients Manufacturing Industry?

North America was the largest region in the veterinary active pharmaceutical ingredients manufacturing market in 2024. The regions covered in the veterinary active pharmaceutical ingredients manufacturing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7942

This Report Delivers Insight On:

1. How big is the veterinary active pharmaceutical ingredients manufacturing market, and how is it changing globally?

2. Who are the major companies in the veterinary active pharmaceutical ingredients manufacturing market, and how are they performing?

3. What are the key opportunities and risks in the veterinary active pharmaceutical ingredients manufacturing market right now?

4. Which products or customer segments are growing the most in the veterinary active pharmaceutical ingredients manufacturing market?

5. What factors are helping or slowing down the growth of the veterinary active pharmaceutical ingredients manufacturing market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has the Veterinary Active Pharmaceutical Ingredients Manufacturing Market Grown from 2024 to 2025?

The market for manufacturing active pharmaceutical ingredients for veterinary use has been on a significant upward trend in the past few years. The market size is projected to rise from $7.46 billion in 2024 to $8.05 billion in 2025, registering a compound annual growth rate (CAGR) of 7.9%. This growth trajectory seen in the historical period is largely influenced by factors such as an increase in pet ownership, the enforcement of strict regulatory standards, heightened emphasis on animal nutrition, increased investment in research and development, and general global economic growth.

What Growth Rate Is Anticipated for the Veterinary Active Pharmaceutical Ingredients Manufacturing Market in the Coming Years?

The market for manufacturing veterinary active pharmaceutical ingredients is projected to experience robust growth in the coming years, escalating to a worth of $11.19 billion in 2029 with a compound annual growth rate (CAGR) of 8.6%. This projected growth during the forecast period can be credited to factors such as the development of tailored veterinary medicine, global expansion and market proliferation, a heightened focus on regulatory adherence, the growing significance of animal well-being, progress in drug delivery systems, and an increased demand for nutraceuticals. Foreseen trends in this growth span include advancements in manufacturing methodologies, a rising trend in the outsourcing of API manufacturing, a transformation towards biotech-based APIs, the incorporation of digitalization and automation in production, and the globalization of the veterinary API market.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7942&type=smp

Who Are the Leading Companies in the Veterinary Active Pharmaceutical Ingredients Manufacturing Market?

Major companies operating in the veterinary active pharmaceutical ingredients manufacturing market are Alivira Animal Health Limited, Excel Industries Limited, Ofichem Group B.V., Jiangsu Lingyun Pharmaceutical Co. Ltd., SUANFARMA S.A., NGL Fine-Chem Limited, FIS – Fabbrica Italiana Sintetici S.p.A., Lupin Limited, Aurobindo Pharma Limited, Saneca Pharmaceuticals AS, Neuland Laboratories Limited, Divi’s Laboratories Limited, Zoetis Inc., Grupo Indukern S.L., Sequent Scientific Limited, Chempro Pharma Private Limited, AMGIS Lifescience Ltd., Huvepharma AD, Vetpharma Animal Health S.L., Qilu Pharma Spain S.A., INDUKERN Chemie AG, Chemopharma S.A., Norbrook Laboratories Limited, Ceva Santé Animale S.A., Vetoquinol S.A., Virbac S.A.

What Are the Key Drivers of the Veterinary Active Pharmaceutical Ingredients Manufacturing Market?

The rise in pet adoption is anticipated to boost the expansion of the market for manufacturing veterinary active pharmaceutical ingredients. Pet keepers are those who possess or adopt a pet animal and offer necessary healthcare arrangements for their pets, thereby escalating the need for veterinary medicines. As an example, Animal Medicines Australia, a non-profit organization based in Australia, reported a significant increase in pet ownership in the year 2022. They documented an increase from 39% in 2021 to 28,730.8 pet owners in 2022, marking a 24% growth. This indicates a significant surge in the adoption of pets and investments in pet care, underlining the mounting popularity of pets in Australian homes. Consequently, the rising number of individuals owning pets fuels the market for the production of veterinary active pharmaceutical ingredients.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=7942&type=smp

What Are the Key Market Segments in the Veterinary Active Pharmaceutical Ingredients Manufacturing Industry?

The veterinary active pharmaceutical ingredients manufacturing market covered in this report is segmented –

1) By Product: Antiparasitic, Anti-Infectives, Vaccines, NSAIDs

2) By Service Type: In House, Contract Outsourcing

3) By Synthesis Type: Chemical Based API, Biological API, Highly Potent API

Subsegments:

1) By Antiparasitic: Endectocides, Anthelmintics, Antiprotozoals

2) By Anti-Infectives: Antibiotics, Antifungals, Antivirals

3) By Vaccines: Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines

4) By NSAIDs (Non-Steroidal Anti-Inflammatory Drugs): Non-Selective NSAIDs, COX-2 Inhibitors

What Are the Latest Trends in the Veterinary Active Pharmaceutical Ingredients Manufacturing Market?

One significant trend that is emerging in the veterinary active pharmaceutical ingredient manufacturing market is product innovation. To maintain their dominance in the market, the leading companies are focusing on developing innovative products. For example, in January 2022, Zoetis Inc., a US-based company that manufactures drugs for livestock and pets, received approval from the US FDA for Solensia (frunevetmab injection), designed to manage osteoarthritis (OA) pain in cats. Solensia, which is the only injectable monoclonal antibody therapy for feline OA pain approved in the United States, functions by targeting and neutralizing nerve growth factor (NGF), a primary contributor to osteoarthritis pain.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/veterinary-active-pharmaceutical-ingredients-manufacturing-global-market-report

What Are the Key Regional Markets in the Veterinary Active Pharmaceutical Ingredients Manufacturing Industry?

North America was the largest region in the veterinary active pharmaceutical ingredients manufacturing market in 2024. The regions covered in the veterinary active pharmaceutical ingredients manufacturing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7942

This Report Delivers Insight On:

1. How big is the veterinary active pharmaceutical ingredients manufacturing market, and how is it changing globally?

2. Who are the major companies in the veterinary active pharmaceutical ingredients manufacturing market, and how are they performing?

3. What are the key opportunities and risks in the veterinary active pharmaceutical ingredients manufacturing market right now?

4. Which products or customer segments are growing the most in the veterinary active pharmaceutical ingredients manufacturing market?

5. What factors are helping or slowing down the growth of the veterinary active pharmaceutical ingredients manufacturing market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Discover trends, market shifts, and competitive outlooks for the veterinary active pharmaceutical ingredients manufacturing industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

#How Has the Veterinary Active Pharmaceutical Ingredients Manufacturing Market Growth Performance Trended Historically, And What Lies Ahead?

The market size of manufacturing for veterinary active pharmaceutical ingredients has seen substantial growth over the past few years. It is projected to increase from $7.46 billion in 2024 to $8.05 billion in 2025, experiencing a compound annual growth rate (CAGR) of 7.9%. Factors contributing to this growth in the past include a rise in pet ownership, strict regulatory benchmarks, an amplified emphasis on animal nutrition, investments in research and development, as well as global economic expansion.

Predictions anticipate robust expansion in the manufacturing market of veterinary active pharmaceutical ingredients in the coming years, with an expected growth to $11.19 billion in 2029, boasting a compound annual growth rate (CAGR) of 8.6%. The progression in the forecasted phase is credited to advances in customized veterinary medicine, globalization coupled with market expansion, a concentrated approach on regulatory compliance, escalating significance of animal welfare, progressions in drug delivery systems, and surging demand for nutraceuticals. The period in anticipation also reveals certain major trends including technological upgrades in production processes, mounting outsourcing of API manufacturing, a shift towards biotechnology-based APIs, digitalization and automation in production, and globalization of the veterinary API market.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7942&type=smp

What Are the Core Market Drivers Propelling Growth in the Veterinary Active Pharmaceutical Ingredients Manufacturing Industry?

The upsurge in people owning or adopting pets is anticipated to fuel the expansion of the veterinary active pharmaceutical ingredients manufacturing market. These pet owners, by offering crucial health amenities to their pets, stimulate the need for veterinary medicines. For instance, as revealed by Animal Medicines Australia, a non-governmental organization based in Australia, there was a substantial growth in pet ownership in Australia in 2022, totaling 28,730.8, a rise from the 39% in 2021. This further reflects a 24% surge, illustrating a robust augmentation in pet adoption and investment in their care. This rise in pet ownership underlines the escalating favor towards pets in Australian homes. As a result, the escalating number of pet owners is a significant driver shaping the veterinary active pharmaceutical ingredients manufacturing market.

How Is the Veterinary Active Pharmaceutical Ingredients Manufacturing Market Segmented?

The veterinary active pharmaceutical ingredients manufacturing market covered in this report is segmented –

1) By Product: Antiparasitic, Anti-Infectives, Vaccines, NSAIDs

2) By Service Type: In House, Contract Outsourcing

3) By Synthesis Type: Chemical Based API, Biological API, Highly Potent API

Subsegments:

1) By Antiparasitic: Endectocides, Anthelmintics, Antiprotozoals

2) By Anti-Infectives: Antibiotics, Antifungals, Antivirals

3) By Vaccines: Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines

4) By NSAIDs (Non-Steroidal Anti-Inflammatory Drugs): Non-Selective NSAIDs, COX-2 Inhibitors

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=7942&type=smp

Which Regions Are Driving the Next Phase of the Veterinary Active Pharmaceutical Ingredients Manufacturing Market Growth?

North America was the largest region in the veterinary active pharmaceutical ingredients manufacturing market in 2024. The regions covered in the veterinary active pharmaceutical ingredients manufacturing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Key Market Trends and Innovations Are Shaping the Future of the Veterinary Active Pharmaceutical Ingredients Manufacturing Industry?

Product innovation is becoming a critical trend in the veterinary active pharmaceutical ingredient manufacturing market. Major participants in the industry are focusing on creating innovative products to maintain their market standing. For example, in January 2022, Zoetis Inc, a company based in the US that focuses on drugs for pets and livestock, declared that the US FDA had approved Solensia (frunevetmab injection) to manage osteoarthritis (OA) pain in cats. Solensia is unique in being the only approved injectable monoclonal antibody treatment for feline OA pain in the United States. Its effectiveness stems from its ability to target and neutralize nerve growth factor (NGF), a primary contributor to osteoarthritis pain.

View the full report here:

https://www.thebusinessresearchcompany.com/report/veterinary-active-pharmaceutical-ingredients-manufacturing-global-market-report

How Is the Veterinary Active Pharmaceutical Ingredients Manufacturing Market Defined and What Are Its Core Parameters?

Veterinary active pharmaceutical Ingredients (APIs) manufacturing refers to the process of producing chemical compounds that are biologically active and used in the formulation of veterinary medicines. These APIs are essential for treating diseases and managing health in animals, including livestock and pets. The manufacturing process ensures the quality, safety, and efficacy of the medications that improve animal welfare and health outcomes.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7942

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

What Industry-Specific Factors Are Fueling the Growth of theVeterinary Active Pharmaceutical Ingredients Manufacturing Market?

The escalating count of people possessing pets is projected to expedite the expansion of the veterinary active pharmaceutical ingredients manufacturing market. Pet proprietors are individuals who have acquired or adopted a pet. They provide the vital health amenities for their pets which results in the rising demand for veterinary medications. For instance, data from Animal Medicines Australia, an Australian not-for-profit organization, in 2022 showcased a substantial growth in pet ownership in Australia. The number of pet owners rose to 28,730.8 in 2022, a marked uptick from 39% in 2021. This exhibits a 24% increase, showcasing a robust positive momentum in pet adoption and expenditure on their care. The escalation in pet ownership signifies the growing trend of keeping pets in Australian homes. Consequently, the burgeoning pool of pet owners is fueling the growth of the veterinary active pharmaceutical ingredients manufacturing market.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7942&type=smp

#What Are the Key Projections for the CAGR of the Veterinary Active Pharmaceutical Ingredients Manufacturing Market From 2025 to 2034?

The market for manufacturing veterinary active pharmaceutical ingredients has seen powerful growth in the past few years. The market size is projected to increase from $7.46 billion in 2024 to $8.05 billion in 2025, indicating a compound annual growth rate (CAGR) of 7.9%. Factors such as the increase in pet ownership, strict regulatory norms, heightened concentration on animal nutrition, investments in research and development, and the worldwide economic growth have played a significant role in the market’s growth during the historic period.

The market for manufacturing veterinary active pharmaceutical ingredients is predicted to experience robust growth in the coming years. It’s anticipated that it will reach $11.19 billion by 2029, growing at a compound annual growth rate (CAGR) of 8.6%. The expected growth in the forecast period is due to factors such as the evolution in personalized veterinary medicine, market expansion and globalization, emphasis on regulatory conformity, the increasing value of animal welfare, advancements in drug delivery systems, and the growing demand for nutraceuticals. Key trends for the predicted period encompass technological improvement in manufacturing processes, a rise in the outsourcing of API manufacturing, a shift towards biotechnology-based APIs, implementation of digitalization and automation in manufacturing, and the internationalization of the veterinary API market.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7942

What Key Market Trends and Innovations Are Shaping the Future of theVeterinary Active Pharmaceutical Ingredients Manufacturing Industry?

A key trend in the veterinary active pharmaceutical ingredient manufacturing market is product innovation. To maintain their standing in the market, major players are focusing on the development of innovative products. For instance, Zoetis Inc., a U.S.-based firm specializing in drugs for pets and livestock, announced in January 2022 the approval by the U.S. FDA of their product, Solensia (frunevetmab injection). This product is intended for the management of osteoarthritis (OA) pain in cats. Uniquely, Solensia is the only injectable monoclonal antibody solution for feline OA pain approved in the U.S., which works by targeting and neutralizing nerve growth factor (NGF), a primary cause of pain in osteoarthritis.

Which Companies Are Leading the Charge in Expanding theVeterinary Active Pharmaceutical Ingredients Manufacturing Market Growth?

Major companies operating in the veterinary active pharmaceutical ingredients manufacturing market are Alivira Animal Health Limited, Excel Industries Limited, Ofichem Group B.V., Jiangsu Lingyun Pharmaceutical Co. Ltd., SUANFARMA S.A., NGL Fine-Chem Limited, FIS – Fabbrica Italiana Sintetici S.p.A., Lupin Limited, Aurobindo Pharma Limited, Saneca Pharmaceuticals AS, Neuland Laboratories Limited, Divi’s Laboratories Limited, Zoetis Inc., Grupo Indukern S.L., Sequent Scientific Limited, Chempro Pharma Private Limited, AMGIS Lifescience Ltd., Huvepharma AD, Vetpharma Animal Health S.L., Qilu Pharma Spain S.A., INDUKERN Chemie AG, Chemopharma S.A., Norbrook Laboratories Limited, Ceva Santé Animale S.A., Vetoquinol S.A., Virbac S.A.

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/veterinary-active-pharmaceutical-ingredients-manufacturing-global-market-report

How is the Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market Segemented?

The veterinary active pharmaceutical ingredients manufacturing market covered in this report is segmented –

1) By Product: Antiparasitic, Anti-Infectives, Vaccines, NSAIDs

2) By Service Type: In House, Contract Outsourcing

3) By Synthesis Type: Chemical Based API, Biological API, Highly Potent API

Subsegments:

1) By Antiparasitic: Endectocides, Anthelmintics, Antiprotozoals

2) By Anti-Infectives: Antibiotics, Antifungals, Antivirals

3) By Vaccines: Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines

4) By NSAIDs (Non-Steroidal Anti-Inflammatory Drugs): Non-Selective NSAIDs, COX-2 Inhibitors

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=7942&type=smpGlobal Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market Report, Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market Trends, Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size

Browse Through More Reports Similar to the Gobal Veterinary Active Pharmaceutical Ingredients Manufacturing Maret 2025, By The Business Research Company:

Veterinary Patient Monitoring Equipment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/veterinary-patient-monitoring-equipment-global-market-report

Veterinary Diagnostic Equipment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/veterinary-diagnostic-equipment-global-market-report

Veterinary Antibiotics Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/veterinary-antibiotics-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What Growth Opportunities are Expected to Drive the Veterinary Active Pharmaceutical Ingredients Manufacturing Market’s CAGR Through 2034?

The market for manufacturing veterinary active pharmaceutical ingredients has seen substantial expansion in the past few years. The market is poised to grow from $7.46 billion in 2024 to about $8.05 billion in 2025, demonstrating an impressive compound annual growth rate (CAGR) of 7.9%. The unprecedented growth observed in the historical period can be linked to factors such as an increase in pet adoption, stringent regulatory norms, heightened attention to animal nutrition, investments in R&D, and overall global economic expansion.

In the coming years, the market for veterinary active pharmaceutical ingredients is predicted to expand significantly. It is projected to reach a value of $11.19 billion by 2029, with a compound annual growth rate (CAGR) of 8.6%. This upswing during the forecast period is anticipated due to progress in customized veterinary medication, market extension and globalization, emphasis on regulatory adherence, increasing significance of animal welfare, advancements in drug delivery systems, and a higher demand for nutraceuticals. The major market trends to observe during the forecast period encompass technological progress in manufacturing methods, a rising trend in the outsourcing of API manufacturing, a shift towards biotechnology-based APIs, the automation and digitalization of manufacturing, and the international expansion of the veterinary API market.

What Are the Primary Drivers Supporting the Growth of the veterinary active pharmaceutical ingredients manufacturing Market?

The surge in pet adoption is expected to drive the growth of the veterinary active pharmaceutical ingredients manufacturing market forward. Individuals who own or adopt a pet are often responsible for providing them with essential health services, inevitably increasing the demand for veterinary drugs. Animal Medicines Australia, a non-governmental organization based in Australia, reported a significant rise in pet ownership in 2022. With the number of pet owners reaching 28,730.8 in 2022, this was a significant increase from 39% in 2021. This 24% increase showcases a positive trend in pet adoption and investment in their care. The continued rise in pet ownership in Australian homes emphasizes the growing appeal of pets. Consequently, the escalating number of pet owners is fueling the growth of the veterinary active pharmaceutical ingredients manufacturing market.

Explore Comprehensive Insights Into The Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market With A Free Sample Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7942&type=smp

What Are the Leading Industry Players Dominating the Veterinary Active Pharmaceutical Ingredients Manufacturing Market?

Major companies operating in the veterinary active pharmaceutical ingredients manufacturing market are:

• Alivira Animal Health Limited_x000D_

• Excel Industries Limited_x000D_

• Ofichem Group B.V._x000D_

• Jiangsu Lingyun Pharmaceutical Co. Ltd._x000D_

• SUANFARMA S.A._x000D_

What Are the Latest Trends Leading to Disruption in the Veterinary Active Pharmaceutical Ingredients Manufacturing Market?

Product innovation is emerging as a notable trend in the marketplace for veterinary active pharmaceutical ingredients. The major contenders in this market are tapping into innovative offerings to keep their market positions secure. For instance, Zoetis Inc., a pharmaceutical brand based in the U.S. that caters to pets and livestock, got the nod from the US FDA in January 2022 for Solensia (frunevetmab injection), a treatment for pain caused by osteoarthritis (OA) in cats. Solensia, being the sole injectable monoclonal antibody treatment for feline OA pain to be granted approval in the United States, operates by neutralizing nerve growth factor (NGF), a prominent contributor to pain in osteoarthritis conditions.

Secure Your Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market Report Now for Fast and Efficient Delivery!

https://www.thebusinessresearchcompany.com/report/veterinary-active-pharmaceutical-ingredients-manufacturing-global-market-report

What Are the Core Categories and Segments in the Veterinary Active Pharmaceutical Ingredients Manufacturing Market Driving Demand and Growth?

The veterinary active pharmaceutical ingredients manufacturing market covered in this report is segmented –

1) By Product: Antiparasitic, Anti-Infectives, Vaccines, NSAIDs

2) By Service Type: In House, Contract Outsourcing

3) By Synthesis Type: Chemical Based API, Biological API, Highly Potent API

Subsegments:

1) By Antiparasitic: Endectocides, Anthelmintics, Antiprotozoals

2) By Anti-Infectives: Antibiotics, Antifungals, Antivirals

3) By Vaccines: Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines

4) By NSAIDs (Non-Steroidal Anti-Inflammatory Drugs): Non-Selective NSAIDs, COX-2 Inhibitors

Which Regions Are Significant to the Growth of the Veterinary Active Pharmaceutical Ingredients Manufacturing Market?

North America was the largest region in the veterinary active pharmaceutical ingredients manufacturing market in 2024. The regions covered in the veterinary active pharmaceutical ingredients manufacturing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

How Is the Veterinary Active Pharmaceutical Ingredients Manufacturing Market Classified and Defined in Market Analysis?

Veterinary active pharmaceutical Ingredients (APIs) manufacturing refers to the process of producing chemical compounds that are biologically active and used in the formulation of veterinary medicines. These APIs are essential for treating diseases and managing health in animals, including livestock and pets. The manufacturing process ensures the quality, safety, and efficacy of the medications that improve animal welfare and health outcomes.

Browse Through More Similar Reports By The Business Research Company:

Veterinary Patient Monitoring Equipment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/veterinary-patient-monitoring-equipment-global-market-report

Veterinary Diagnostic Equipment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/veterinary-diagnostic-equipment-global-market-report

Veterinary Antibiotics Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/veterinary-antibiotics-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: